Laser-assisted delivery enhances topical uptake of the anticancer agent cisplatin

References

• Bacro TR, Holladay EB, Stith MJ, et al. (2000). Iontophoresis treatment of basal cell carcinoma with cisplatin: a case report. Cancer Detect Prev. 24:610–9.
   PubMedGoogle Scholar
• Bejar C, Maubec E. (2014). Therapy of advanced squamous cell carcinoma of the skin. Curr Treat Options Oncol. 15:302–20.
   PubMed Web of Science ®Google Scholar
• Brouwers EE, Huitema AD, Beijnen JH, Schellens JH. (2008). Long-term platinum retention after treatment with cisplatin and oxaliplatin. BMC Clin Pharmacol. 8:7.
   PubMedGoogle Scholar
• Byrne JD, Jajja RMN, O’Neill AT, et al. (2015). Local iontophoretic administration of cytotoxic therapies to solid tumors. Sci Transl Med. 7:273ra14.
   PubMed Web of Science ®Google Scholar
• Chabner BA, Longo DL, Grem LJ, et al. (2015). Cancer chemotherapy and biotherapy: principles and practice. Philadelphia: Wolters Kluwer Health.
   Google Scholar
• Chang BK, Guthrie TH, Jr., Hayakawa K, Gangarosa LP. Sr. (1993). A pilot study of iontophoretic cisplatin chemotherapy of basal and squamous cell carcinomas of the skin. Arch Dermatol. 129:425–7.
   PubMed Web of Science ®Google Scholar
• Chang CE, Hsieh CM, Chen LC, et al. (2018). Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer. Drug Deliv. 25:632–43.
   PubMed Web of Science ®Google Scholar
• Chang Q, Ornatsky OI, Siddiqui I, et al. (2016). Biodistribution of cisplatin revealed by imaging mass cytometry identifies extensive collagen binding in tumor and normal tissues. Sci Rep. 6:36641.
   PubMed Web of Science ®Google Scholar
• Erlendsson AM, Doukas AG, Farinelli WA, et al. (2016). Fractional laser-assisted drug delivery: active filling of laser channels with pressure and vacuum alteration. Lasers Surg Med. 48:116–24.
   PubMed Web of Science ®Google Scholar
• Featherstone J, Dykes PJ, Marks R. (1991). The effect of platinum complexes on human skin cells in vivo and in vitro. Skin Pharmacol. 4:169–74.
   PubMedGoogle Scholar
• Ghezzi A, Aceto M, Cassino C, et al. (2004). Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS). J Inorg Biochem. 98:73–8.
   PubMed Web of Science ®Google Scholar
• Gil S, Yebenes M, Luelmo J, et al. (2016). A comparative study of the effectiveness of cisplatin and 5-fluorouracil on cutaneous squamous human carcinoma cell line: potential chemotherapy alternative to surgery. Dermatol Ther. 29:341–4.
   PubMed Web of Science ®Google Scholar
• Gouyette A, Apchin A, Foka M, Richard JM. (1986). Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients. Eur J Cancer Clin Oncol. 22:257–63.
   PubMedGoogle Scholar
• Gupta V, Dhote V, Paul BN, Trivedi P. (2014). Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancy. J Liposome Res. 24:150–62.
   PubMed Web of Science ®Google Scholar
• Guthrie TH Jr., Mcelveen LJ, Porubsky ES, Harmon JD. (1985). Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin. Cancer. 55:1629–32.
   PubMed Web of Science ®Google Scholar
• Haedersdal M, Erlendsson AM, Paasch U, Anderson RR. (2016). Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status. J Am Acad Dermatol. 74:981–1004.
   PubMed Web of Science ®Google Scholar
• Hecquet B, Caty A, Fournier C, et al. (1987). Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin. Bull Cancer. 74:433–6.
   PubMed Web of Science ®Google Scholar
• Hecquet B, Vennin P, Fournier C, et al. (1985). Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin. Cancer Chemother Pharmacol. 15:310–2.
   PubMed Web of Science ®Google Scholar
• Hewes CA, Sullins KE. (2006). Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000–2004). J Am Vet Med Assoc. 229:1617–22.
   PubMed Web of Science ®Google Scholar
• Holding JD, Lindup WE, Bowdler DA, et al. (1991). Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck. Br J Clin Pharmacol. 32:173–9.
   PubMed Web of Science ®Google Scholar
• Inchem. (1991). Platinum. Available at: http://inchem.org/documents/ehc/ehc/ehc125.htm - SectionNumber:7.3 [Accessed 10 March 2017].
   Google Scholar
• Kitchell BK, Orenberg EK, Brown DM, et al. (1995). Intralesional sustained-release chemotherapy with therapeutic implants for treatment of canine sun-induced squamous cell carcinoma. Eur J Cancer. 31A:2093–8.
   PubMed Web of Science ®Google Scholar
• Leo A, Hoekman D, Hansch C. (1995). "Octanol logP". Exploring QSAR, hydrophobic, electronic, and steric constants. Washington DC: American Chemical Society.
   Google Scholar
• Marwah H, Garg T, Goyal AK, Rath G. (2016). Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 23:564–78.
   PubMed Web of Science ®Google Scholar
• Miatmoko A, Kumi K, Hattori Y, et al. (2015). Evaluation of transfersome and protransfersome for percutaneous delivery of cisplatin in hairless mice. J Pharm Pharmacol. S(1):7.
   Google Scholar
• Moeholt K, Aagaard H, Pfeiffer P, Hansen O. (1996). Platinum-based cytotoxic therapy in basal cell carcinoma-a review of the literature. Acta Oncol. 35:677–82.
   PubMed Web of Science ®Google Scholar
• O'neil MJ, Ed (2006). The Merck Index: an encyclopedia of chemicals, drugs, and biologicals. New Jersey: Merck.
   Google Scholar
• Olesen UH, Bojesen S, Gehl J, Haedersdal M. (2017). Anticancer drugs and the regulation of Hedgehog genes GLI1 and PTCH1, a comparative study in nonmelanoma skin cancer cell lines. Anticancer Drugs. 28:1106–17.
   PubMed Web of Science ®Google Scholar
• Persson DP, Chen A, Aarts MG, et al. (2016). Multi-element bioimaging of Arabidopsis thaliana roots. Plant Physiol. 172:835–47.
   PubMed Web of Science ®Google Scholar
• Salem P, Hall SW, Benjamin RS, et al. (1978). Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion. Cancer Treat Rep. 62:1553–5.
   PubMedGoogle Scholar
• Sersa G, Stabuc B, Cemazar M, et al. (1998). Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer. 34:1213–8.
   PubMed Web of Science ®Google Scholar
• Simonetti LD, Gelfuso GM, Barbosa JC, Lopez RF. (2009). Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. Eur J Pharm Biopharm. 73:90–4.
   PubMed Web of Science ®Google Scholar
• Taudorf EH, Lerche CM, Vissing AC, et al. (2015). Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation. Expert Opin Drug Deliv. 12:1059–69.
   PubMed Web of Science ®Google Scholar
• Taveira SF, Lopez RFV. (2011). Topical administration of anticancer drugs for skin cancer treatment. In: Skin cancers—risk, factors, prevention and therapy. Rijeka, Croatia: InTech.
   Google Scholar
• Trodello C, Pepper JP, Wong M, Wysong A. (2017). Cisplatin and cetuximab treatment for metastatic cutaneous squamous cell carcinoma: a systematic review. Dermatol Surg. 43:40–9.
   PubMed Web of Science ®Google Scholar
• Uddin MJ, Scoutaris N, Klepetsanis P, et al. (2015). Inkjet printing of transdermal microneedles for the delivery of anticancer agents. Int J Pharm. 494:593–602.
   PubMed Web of Science ®Google Scholar
• Wenande E, Erlendsson AM, Haedersdal M. (2017a). Opportunities for laser-assisted drug delivery in the treatment of cutaneous disorders. Semin Cutan Med Surg. 36:192–201.
   PubMed Web of Science ®Google Scholar
• Wenande E, Olesen UH, Nielsen MM, et al. (2017b). Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake. Expert Opin Drug Deliv. 14:307–17.
   PubMed Web of Science ®Google Scholar
• Wenande E, Tam J, Bhayana B, et al. (2018). Laser-assisted delivery of synergistic combination chemotherapy in in vivo skin. J Control Release. 275:242–53.
   PubMed Web of Science ®Google Scholar